NEW YORK-- (BUSINESS WIRE) -- Attorney Advertising. Notice is hereby given that Stull, Stull & Brody has commenced an investigation on behalf of shareholders of Trimeris, Inc. (“Trimeris” or the “Company”) (Nasdaq: TRMS) for possible breaches of fiduciary duty and other violations of state law in connection with an agreement by the Trimeris Board of Directors to sell all of the Company’s outstanding shares of common stock at a price of $3.60 per share to Arigene Co., Ltd. (“Arigene”).

If you own the common stock of Trimeris and wish to obtain additional information about this matter, please contact Stull, Stull & Brody at the toll-free number listed below. Stull, Stull & Brody has litigated many class actions for violations of securities laws and breaches of fiduciary duties on behalf of defrauded investors over the past 40 years and has obtained court approval of substantial settlements on numerous occasions.

The investigation concerns the price to be paid by Arigene to Trimeris shareholders and the process by which the Trimeris Board of Directors is addressing the transaction. Given that Trimeris common stock was trading at $3.68 per share as recently as October 2, 2009, Stull, Stull & Brody is investigating whether the Trimeris Board of Directors breached their fiduciary duties owed to Trimeris shareholders in violation of state law by not acting in the best interests of the Company’s shareholders in connection with the transaction.

If you wish to discuss this matter or have any questions concerning this notice or your rights or interests with respect to this matter, please contact Aaron Brody, Esq. at Stull, Stull & Brody by calling 1-800-337-4983 or 1-212-687-7230, or by email to ssbny@aol.com or by writing to Stull, Stull & Brody, 6 East 45^th Street, New York, NY 10017.

Attorney advertising. Prior results do not guarantee a similar outcome.